Summit Therapeutics SMMT
NASDAQ SMMT
$15.47 -0.08 (-0.51%)
At close: Oct 23, 2026 · 4:00 PM EDT

Summit Therapeutics (SMMT) Asset Writedowns and Impairment (2018 - 2023)

Updated

Summit Therapeutics (SMMT) reported Asset Writedowns and Impairment of $474,000 for FY2023, down 94.4% from $8.47 million in FY2022.

Analysis

Summit Therapeutics (SMMT) Asset Writedowns and Impairment (2018 - 2023) Analysis & Trends

Dating back to FY2018, Summit Therapeutics' Asset Writedowns and Impairment record includes 4 years.

  • Asset Writedowns and Impairment has a five-year compound annual growth rate of -38.3% (FY2018 to FY2023).
  • According to Business Quant data, Asset Writedowns and Impairment came in at $8.47 million in FY2022 and $859,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Summit Therapeutics 12.05 Bn 9.81 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 474,000.00
Dec 31, 2022 8.47 Mn
Sep 30, 2020 859,000.00
Jul 31, 2018 5.31 Mn
API Access

Summit Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=SMMT&period=max&api_key=YOUR_API_KEY